NCT03094845
- Conditions
- Dust Mite Allergy, House Dust Mite Allergy, Hypersensitivity, +9 more
- Locations
-
- Universitätsklinikum Carl Gustav Carus Dresden, Germany
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,753 public trials
646 recruiting studies
Hypersensitivity trial results
- Conditions
- Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +21 more
- Locations
-
- Novartis Investigative Site Brussels, Belgium
- Novartis Investigative Site Laken, Belgium
- Novartis Investigative Site Toronto, Ontario, Canada
- Novartis Investigative Site Le Kremlin-Bicêtre, France
NCT00379678
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- National Jewish Medical and Research Center Denver, Colorado, United States
NCT01879592
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +16 more
- Locations
-
- Nemours Children's Clinic Wilmington, Delaware, United States
- Nemours Children's Clinic Jacksonville, Florida, United States
- Nemours Children's Clinic Orlando, Florida, United States
NCT00443482
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Novartis Investigative Site Berlin, Germany
- Novartis Investigative Site Bovenden--Lengler, Germany
- Novartis Investigative Site Marburg, Germany
- Novartis Investigative Site Wiesbaden, Germany
NCT00463827
- Conditions
- Asthma, Behavior, Bronchial Diseases, +14 more
- Locations
-
- Gartnavel General Hospital Glasgow, United Kingdom
NCT01149759
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- The Rockefeller University New York, United States
NCT00564421
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
Not specified
NCT00873860
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Research Site Burgas, Bulgaria
- Research Site Plovdiv, Bulgaria
- Research Site Rousse, Bulgaria
- Research Site Rousse, Bulgaria
Completed
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
NCT00635089
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
- Locations
-
- The Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Arizona Dept. of Pediatrics Tucson, Arizona, United States
- Arkansas Children's Hospital/University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Kaiser Permanente Hospital- Pediatric Gastroenterology Hayward, California, United States